论文信息 - Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer - 字舞流文

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

Wendy S. Becker | G. Groenewegen | M. Eisenhut | H. Steininger | J. Kalden | M. Gramatzki | R. Repp | J. V. D. van de Winkel | T. Valerius | G. Blijham | Y. Deo | B. Stockmeyer | H. V. van Ojik | G. Wieland | C. Oetzel